Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP622971.RAFsaK8Hl8eErlk2tgW_SC8uWfG6RviCZlwAc6_eUWbE0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP622971.RAFsaK8Hl8eErlk2tgW_SC8uWfG6RviCZlwAc6_eUWbE0130_assertion type Assertion NP622971.RAFsaK8Hl8eErlk2tgW_SC8uWfG6RviCZlwAc6_eUWbE0130_head.
- NP622971.RAFsaK8Hl8eErlk2tgW_SC8uWfG6RviCZlwAc6_eUWbE0130_assertion description "[The PI3K/AKT pathway is hyperactivated in prostate cancer but its effective therapeutic targeting has proven difficult.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP622971.RAFsaK8Hl8eErlk2tgW_SC8uWfG6RviCZlwAc6_eUWbE0130_provenance.
- NP622971.RAFsaK8Hl8eErlk2tgW_SC8uWfG6RviCZlwAc6_eUWbE0130_assertion evidence source_evidence_literature NP622971.RAFsaK8Hl8eErlk2tgW_SC8uWfG6RviCZlwAc6_eUWbE0130_provenance.
- NP622971.RAFsaK8Hl8eErlk2tgW_SC8uWfG6RviCZlwAc6_eUWbE0130_assertion SIO_000772 23585456 NP622971.RAFsaK8Hl8eErlk2tgW_SC8uWfG6RviCZlwAc6_eUWbE0130_provenance.
- NP622971.RAFsaK8Hl8eErlk2tgW_SC8uWfG6RviCZlwAc6_eUWbE0130_assertion wasDerivedFrom befree-20150227 NP622971.RAFsaK8Hl8eErlk2tgW_SC8uWfG6RviCZlwAc6_eUWbE0130_provenance.
- NP622971.RAFsaK8Hl8eErlk2tgW_SC8uWfG6RviCZlwAc6_eUWbE0130_assertion wasGeneratedBy ECO_0000203 NP622971.RAFsaK8Hl8eErlk2tgW_SC8uWfG6RviCZlwAc6_eUWbE0130_provenance.